Immunoglobulin M Oligoclonal Bands: Biomarker of Targetable Inflammation in Primary Progressive Multiple Sclerosis

Date
2014
Author
Comabella, Manuel
Jalili, Farzaneh
Leppert, David
de Andres, Clara
Montalban, Xavier
Fernandez, Oscar
Alvarez-Lafuente, Roberto
Masterman, Donna
Garcia-Sanchez, Maria I.
Coret, Francisco
Evdoshenko, Evgeniy
Alvarez-Cermeno, Jose C.
Bar-Or, Amit
Siva, Aksel
Villar, Luisa M.
Casanova, Bonaventura
Ouamara, Nadia
Izquierdo, Guillermo
Arroyo, Rafael
Avsar, Timucin
Lapin, Sergey V.
Johnson, Trina
Metadata
Show full item record
Abstract
Objective: To identify a biomarker distinguishing patients who, despite a primary progressive multiple sclerosis (PPMS) clinical course, may nonetheless benefit from immune therapy.
URI
http://hdl.handle.net/20.500.12627/16415
https://doi.org/10.1002/ana.24190
Collections